News from irras A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 06, 2021, 02:46 ET IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow

IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced a...

Mar 30, 2021, 02:47 ET IRRAS publishes annual report for 2020

IRRAS's annual report 2020 has today been published on the company's website. The report is available on:...

Mar 23, 2021, 03:24 ET IRRAS to Present at Redeye

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that company...

Mar 09, 2021, 03:00 ET IRRAS Announces the recruitment of Sten Gustafsson as Director of Investor Relations

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that the hiring of...

Feb 16, 2021, 02:17 ET IRRAS AB publishes Year End Report for the period January to December 2020

Growth despite COVID-19 resurgence "During the course of the 4th quarter, challenges associated with the COVID-19 global pandemic increased and...

Feb 09, 2021, 02:14 ET Q4 Report 2020 - invitation to conference call and audiocast

On Tuesday February 16, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q4 2020 interim report (which will have...

Jan 12, 2021, 02:11 ET IRRAS Announces Collaboration with Karolinska University Hospital

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Jan 05, 2021, 04:16 ET IRRAS to Present at H.C. Wainwright Virtual BioConnect Conference

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Dec 17, 2020, 02:21 ET IRRAS Announces Expansion of IRRAflow Launch to Southeastern Europe

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Dec 10, 2020, 02:24 ET IRRAS Announces Expansion of IRRAflow Launch to Latin America

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Nov 26, 2020, 02:16 ET IRRAS Announces Expansion of IRRAflow Launch to The Netherlands

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Nov 17, 2020, 02:26 ET IRRAS Awarded Breakthrough Technology Purchasing Agreement with Premier for Hummingbird ICP Monitoring Products

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Nov 10, 2020, 02:59 ET IRRAS AB publishes Interim Report for the period January to September 2020

"During the third quarter IRRAS made decisive progress in a number of areas. Sales growth was seen again as commercial activity resumed after being...

Nov 04, 2020, 02:21 ET IRRAS: Q3 Report 2020 - invitation to conference call and audiocast

On Tuesday November 10, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q3 2020 interim report (which will have...

Oct 22, 2020, 05:44 ET IRRAS Announces Key IRRAflow Commercial Milestones in Germany

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Sep 29, 2020, 04:13 ET IRRAS Announces Release of Clinical Data that Validates Safety and Effectiveness of IRRAflow System in Treating Chronic Subdural Hematomas

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Aug 25, 2020, 04:13 ET IRRAS Granted Sixth Patent for Hummingbird ICP Monitoring Product Line from United States Patent and Trademark Office (USPTO)

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Aug 20, 2020, 02:10 ET IRRAS: Q2 Report 2020 - invitation to conference call and audiocast

On Thursday August 27, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q2 2020 interim report (which will have been ...

Aug 11, 2020, 04:15 ET IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Aug 05, 2020, 02:16 ET IRRAS to Present Virtually at Upcoming Investor Conferences

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that company...

Jul 22, 2020, 03:57 ET IRRAS Announces Extension of CE Mark for IRRAflow System Until May 2024

IRRAS AB, a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced ...

Jun 30, 2020, 04:14 ET COVID-19 Delays Short Term Revenue, While the Commercial Launch of IRRAflow and Hummingbird Progresses

IRRAS AB, a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today provided...

Jun 15, 2020, 02:49 ET IRRAS Announces Promotion of Will Martin to President and Chief Commercial Officer

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced the promotion of...

May 19, 2020, 11:17 ET IRRAS has Been Approved for Listing on Nasdaq Stockholm and Publishes Prospectus

IRRAS AB (publ) ("IRRAS", or the "Company") announces that Nasdaq Stockholm's listing committee has approved the Company for listing on Nasdaq...

May 11, 2020, 02:27 ET IRRAS: Q1 Report 2020 - Invitation to Conference Call and Audiocast

On Thursday May 14, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q1 2020 interim report (which will have been...